In 2021, the US Preventative Services taskforce issued a new recommendation statement on screening for hypertension in adults. The statement reaffirms the 2015 USPSTF recommendation concluding with high certainty that screening for hypertension in adults has substantial net benefit.
In 2018 the ESC/ESH published a guideline which retains the 140/90 threshold definition of hypertension, including for patients with chronic kidney disease (CKD), and emphasizes lifestyle interventions as primary treatment, with consideration of antihypertensive drug therapy only in adults at very high risk, eg with established CVD. In many other respects the 2018 guideline is similar to the 2017 ACC/AHA guideline.
In 2017 the ACC/AHA and 9 other specialty organizations published an updated hypertension guideline which, among many changes, redefined elevated blood pressure to lower BP levels, enlarging the population considered potential candidates for monitoring and treatment. Learn more here.
In 2014, panel members of the Eighth Joint National Committee published the results of their evidence review and deliberations about the prevention, detection, evaluation, and treatment of high blood pressure.
The 2014 guideline offers recommendations for the management of hypertension in:
Treatment Algorithm
Appendix
Past JNC Reports: JNC 7 | JNC 6 | JNC 5 | JNC 4 | JNC 3 | JNC 2 | JNC 1